CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
QNME
Quanome Technologies, Inc.
There isn't enough reported data to score QNME yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
QNME Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Weak |
QNME's revenue, profitability, cash flow and balance sheet are all currently weak.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
QNME PE Valuation
QNME has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
QNME Forward outlook
There aren't enough analyst estimates for QNME to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over QNME on earnings quality, reporting a profit while its opponent remains loss making.
QNME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.36 | +$0.33 |
| Q1 2026 | -$0.27 | +$0.31 |
| Q4 2025 | -$0.42 | +$0.02 |
| Q3 2025 | -$0.60 | -$0.43 |
| Q2 2025 | -$0.69 | -$0.66 |
| Q1 2025 | -$0.58 | -2033% |
| Q4 2024 | -$0.44 | -980% |
| Q3 2024 | -$0.17 | -343% |
QNME is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.69 at its worst in mid-2025.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over QNME on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over QNME on profitability, with a higher operating margin.
QNME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $742.3K | -88% |
| Q1 2026 | $1.3M | -65% |
| Q4 2025 | $7M | +95% |
| Q3 2025 | $6.1M | +49% |
| Q2 2025 | $6.3M | +32% |
| Q1 2025 | $3.8M | -15% |
| Q4 2024 | $3.6M | -27% |
| Q3 2024 | $4.1M | -1.6% |
QNME's revenue is shrinking: $742,294 last quarter, down 88% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -915% | -907 points |
| Q1 2026 | -119% | -91 points |
| Q4 2025 | -21% | +34 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -8.9% | -24 points |
| Q1 2025 | -28% | -29 points |
| Q4 2024 | -56% | -57 points |
| Q3 2024 | -33% | -25 points |
QNME's operating margin was −915% last quarter, down 907 points from the same quarter a year ago, near the bottom of its range since 2022.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the stronger cash trend. Its trailing FCF is up 39% versus its history, compared with QNME at down 286%.
QNME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | -$497.4K | -$282.2K |
| Q1 2025 | -$238.3K | -$142.1K |
| Q4 2024 | -$560.5K | -358% |
| Q3 2024 | -$1.4M | -3130% |
| Q2 2024 | -$215.3K | -$154.1K |
| Q1 2024 | -$96.2K | -171% |
| Q4 2023 | $217.5K | +600% |
| Q3 2023 | $46.5K | +$107K |
QNME has burned cash in most quarters: −$3M over the past year, against −$47,507 the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over QNME on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
QNME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +76% | +14.9M shares |
| 1 year | +359% | +26.9M shares |
| 3 years | +359% | +26.9M shares |
QNME has 34M diluted shares, up 359% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $74,229 |
| Q3 2024 | $879,574 |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
QNME Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2024 | 312.5x | High |
| Q1 2024 | 3.3x | Elevated |
| Q4 2023 | 3.4x | Elevated |
| Q3 2023 | 3.3x | Elevated |
| Q2 2023 | 2.4x | Moderate |
QNME's net debt is more than 20 years of its operating earnings (EBITDA), up from 2.4 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
QNME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 10.2 | Oversold |
QNME's weekly RSI is 43 (neutral) and its Stochastic is 10 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
QNME PE vs Industrials Sector
QNME has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has stronger trend alignment. CAT is above 2 of 5 weekly averages versus QNME above 0 of 4.
QNME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.51 | 35% below |
| 20 week MA | $0.44 | 25% below |
| 50 week MA | $0.61 | 46% below |
| 100 week MA | $0.95 | 65% below |
QNME is in a downtrend: it's below all four of its weekly moving averages, and 65% below its 100-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over QNME on returns for 2026, with the stronger performance.
QNME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $4.01 | $2.59 | -35% |
| 2025 | $2.59 | $0.91 | -65% |
| 2026 YTD | $0.91 | $0.33 | -64% |
QNME has finished every year since 2024 lower, and it's down 64% so far in 2026.